Navigation Links
ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
Date:4/15/2011

TORONTO, April 15, 2011 /PRNewswire/ -- ClearCanvas Inc., an innovative medical imaging informatics company, today announced the commercial release of their clinical radiology workstation product, ClearCanvas Workstation, Clinical Edition. This marks the first time ClearCanvas has offered a commercial version of their widely accepted Workstation software, previously only offered as an open source application.

ClearCanvas open source software has been employed for over five years, with more than 14,000 worldwide users in a number of clinical settings. With such extensive application, commercial versions of the products were an obvious next step. ClearCanvas RIS/PACS recently received FDA 510(k) clearance. This important regulatory status allows for commercial distribution of the ClearCanvas software.

The ClearCanvas Workstation, Clinical Edition is available for purchase from the eStore on the ClearCanvas website as well as through a small but rapidly growing number of resellers worldwide.

ClearCanvas expects to release a commercial version of their PACS software suite in Q2 2011 with the commercial release of their RIS following in Q4 2011. Additional versions of the Workstation are already planned for 2011; product upgrades and technical support are included free of charge during the first license year. ClearCanvas will continue to release new versions of their open source software as well.  

"Open source products have always been an integral part of who we are and that will not change," states Norman Young, company President and Founder. "At the same time, we also recognize how important it is to create a vibrant commercial ecosystem by bringing our products to different markets around the world. We are extremely excited to offer what so many of our users have been asking for -- a commercial, FDA-cleared version of our very popular Workstation product."

About ClearCanvas Inc.

ClearCanvas Inc. develops innova
'/>"/>

SOURCE ClearCanvas Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioLegend Releases Brilliant Violet 421™ Antibody Conjugates For Advanced Flow Cytometry Applications.
2. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
3. Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
4. OriGene Releases Bioactive Full-length Human MTOR Protein
5. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
6. Waters Releases NuGenesis SDMS 7.1 Validated to Support Windows 7 and Empower 3 CDS
7. OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
8. ACTE Releases Issue Brief Outlining Critical Role CTE Plays in Worker Retraining
9. Elsevier Releases Image Search; New SciVerse ScienceDirect Feature Enables Researchers to Quickly Find Reliable Visual Content
10. Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
11. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... COPENHAGEN, Denmark , April 28, 2015  DanDrit ... a biotechnology company developing a vaccine for the treatment ... has signed a final collaboration agreement with GISCAD Foundation, ... digestive tract cancer studies. The collaboration relates ... vaccine, in patients with no evidence of disease (NED) ...
(Date:4/28/2015)... ANN ARBOR, Mich. , April 28, 2015 ... OncoTargets and Therapy today shows that the Paradigm ... FoundationOne test across a number of key clinical variables, ... The purpose of the analysis was to ... for profiling cancer patients compared with each other.  ...
(Date:4/28/2015)... uBiome, Inc. has announced the ... clinical tests based on its unique microbial assays. ... sparked the era of microbiome-based personalized medicine by ... information about their own bodies using the latest ... uBiome has gathered millions of data points in ...
(Date:4/28/2015)... According to a 2013 report from ... medical treatment from burn injuries per year. Despite several ... formation of scars with subsequent contractures remains a major ... there is no adequate treatment. Contractures are a permanent ... can cause permanent deformity. , Synedgen has developed ...
Breaking Biology Technology:DanDrit Biotech USA, Inc. Announces Final Collaboration Agreement with the GISCAD Foundation 2DanDrit Biotech USA, Inc. Announces Final Collaboration Agreement with the GISCAD Foundation 3DanDrit Biotech USA, Inc. Announces Final Collaboration Agreement with the GISCAD Foundation 4Paradigm Cancer Diagnostic Test (PCDx) Performed Better Than FoundationOne In Side by Side Clinical Study 2Paradigm Cancer Diagnostic Test (PCDx) Performed Better Than FoundationOne In Side by Side Clinical Study 3uBiome Launches Clinical Laboratory 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 3
... at American Society of Pharmacognosy, EMERYVILLE, Calif., ... will present seminal information on a new drug ... 7th Annual Oxford International,Conference on the Science of ... April 12-16, 2008. Scott Baggett, Ph.D., a member ...
... April 14 Codexis, Inc. announced,today that it has ... U.S.,Securities and Exchange Commission ("SEC") relating to the proposed ... of the Codexis,registration statement on Form S-1 can be ... shares being offered and the price,range for the offering ...
... and reduced cost for ... pharmaceutical manufacturers, NEW YORK, ... agreement with Chiral Quest, Inc., a manufacturer and,developer of chiral ... chiral products to the pharmaceutical industry., Effective immediately, Sumitomo ...
Cached Biology Technology:Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness 2Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness 3Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering 2Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest 2
(Date:4/27/2015)... April 27, 2015  For more than four decades, ... has been the premier worldwide event for the unmanned ... a must-attend event for any local, national, or trade ... emerging commercial markets and current applications of unmanned technologies. ... this projected $48 billion industry, and how it will ...
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/27/2015)... Apr. 27, 2015 Profile Solutions, Inc. (OTC: ... security systems is pleased to announce that Dr ... consultant and member of its scientific advisory board. ... as a thought leader in technology-enhanced learning models. He ... and has published studies and books focused on online ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... of Standards and Technology (NIST) will no longer provide ... mercury thermometer calibration program marks the end of an ... the doors opened in 1901. The closing of the ... with the U.S. Environmental Protection Agency (EPA) and a ...
... French . Clostridium difficile ... and other health care facilities, but no new drugs to ... a large-scale, phase 3 trial conducted by Canadian and U.S. ... existing treatments, demonstrating a 45 percent reduction in recurrences vs. ...
... , This release is available in German . ... and is extremely precise: within a few seconds, a laser beam ... screws, clamps or glues whatsoever. The result is a perfect weld ... or particles flying through the air during welding. What,s more: the ...
Cached Biology News:End of an era: NIST to cease calibrating mercury thermometers 2First new C. difficile drug in a generation superior to existing treatments: Researchers 2Laser welding in the right light 2
... Neurotransmitters are stored within neurons ... are concentrated in the synaptic bouton. ... isolated from other cellular ... been proposed in many pathological condtions. ...
... CLS number is a ... to easily match Cornings ... no availability yet, please ... Sigma-Aldrich number (Z71,515-8) or ...
... the value of your microarray data ... the support you need from consultation ... most up to date methods. Utilize ... Gene Expression Profiling Service or from ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...
Biology Products: